Carfilzomib/Cyclophosphamide/Dexamethasone for Newly Diagnosed MM


Carfilzomib/Cyclophosphamide/Dexamethasone for Newly Diagnosed MM
Slides from a presentation at ASH 2013 and transcribed comments from a recent interview with Rafael Fonseca, MD (2/14/14)
Bringhen S et al. A Phase II study with carfilzomib, cyclophosphamide and dexamethasone (CCd) for newly diagnosed multiple myeloma. Proc ASH 2013;Abstract 685.

Dr Fonseca is Getz Family Professor of Cancer and Chair of the Department of Internal Medicine at the Mayo Clinic Arizona in Scottsdale, Arizona.